Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: AB Science, Adagene, Anji, Arca, Arch Biopartners, Astrazeneca, Betterlife, Bonus Biogroup, Daiichi Sankyo, First Wave, Hepagene, Humanigen, Hummingbird, I-Mab, Immutep, Insilico Medicine Hong Kong, Kyowa Kirin, Lintonpharm, Longeveron, Lynk, Mei, Merck, Nrx, Ose Immunotherapeutics, Pulmotect, RDIF, Revive, Ridgeback, Starpharma, Zai Lab.